How the product works:
- Sofosbuvir inhibits NS5B RNA-dependent RNA polymerase, a vital enzyme for HCV replication
- Used in combination with other antivirals such as Ledipasvir, Velpatasvir
- Achieves SVR (sustained virologic response) in 90–95% of cases
- Effective across multiple genotypes and in HIV co-infected individuals
Recommended for:
- Patients with newly diagnosed or recurrent chronic Hepatitis C
- Individuals with hepatic fibrosis or compensated cirrhosis
- HIV/HCV co-infected patients
- Non-responders to interferon-based therapies
Array
(
[actionUrl] => [[+assetsUrl]]action.php
[form] => admin@sacred-leaves.com,idrees@sacred-leaves.com,info@sacred-leaves.com
[formSelector] => ajax_form
[frontend_css] => [[+assetsUrl]]css/default.css
[frontend_js] => [[+assetsUrl]]js/default.js
[objectName] => AjaxForm
[snippet] => FormIt
[hooks] => email
[emailTpl] => tpl.simple-email
[emailSubject] => Сообщение с сайта
[emailTo] => verfut@yandex.ru
[validate] => username:required, tel:required
[validationErrorMessage] => В форме содержатся ошибки!
[successMessage] => Сообщение успешно отправлено
)